Abstract

Background: Women who have a high risk of developing breast cancer due to a familial predisposition or mutations in susceptibility genes undergo adapted screening programs. The earlier onset of screening and higher number of screening moments leaves quite a burden on these women, next to that interval cancers can still occur between scheduled screening moments. Therefore, the prospective, multicenter Dutch TESTBREAST study aims to identify a novel panel of blood-based protein biomarkers. Hereby, the aim is to enable early breast cancer detection for high-risk women using a relatively simple blood test to monitor biomarker levels.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call